Investors in Castle Biosciences (NASDAQ:CSTL) have unfortunately lost 71% over the last three years

By Yahoo! Finance | Jul 25, 2024 at 10:20 AM EST

Despite Castle Biosciences Inc. (NASDAQ:CSTL) experiencing a 71% decline in the past three years, its revenue has grown by 42% annually. The company's profitability issues may be impacting its stock performance, making it essential to assess its financials thoroughly.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.